Introduction
The Platelia ™ (Bio-Rad laboratories, Redmond, WA, USA) Aspergillus enzyme linked immunoassay (EIA) was designed to detect a galactomannan antigen produced by Aspergillus species but cross reactions have been reported with other fungal pathogens, including Histoplasma capsulatum [1] . In an in vitro analysis, culture supernatants of Blastomyces dermatitidis gave positive results in the Platelia ™ Aspergillus EIA [2] . To the best of our knowledge, positive results have not been reported in patients with blastomycosis. Herein we report two patients with blastomycosis whose bronchoalveolar lavage (BAL) fl uids tested positive in the Platelia ™ Aspergillus EIA.
Case reports

Case study 1
A 68-year-old man with diabetes mellitus and rheumatoid arthritis, for which he was receiving infl iximab, presented with a six-week history of worsening cough, dyspnea, and decreased exercise capacity. Chest radiograph and CT scan of quantifi cation [ Ͼ 14.7 ng/ml]), urine (14.33 ng/ml) and serum (above limit of quantifi cation) in the third generation MVista Blastomyces antigen EIA, Table 1 . BAL fl uid also was positive for Aspergillus antigen (0.88 index units) but the serum was negative. Cultures of the BAL fl uid eventually yielded B. dermatitidis , the identifi cation of which was confi rmed by thermal transformation from mold form when grown on Sabouraud and Brain-Heart Infusion agars at 25 ° C to the characteristic yeast on Cotton Seed Agar at 37 ° C. No Aspergillus species or any other mold was isolated from the BAL fl uid.
Discussion
These cases illustrate, although not surprisingly, that the antigen detected in patients with blastomycosis may cause positive results in the Platelia ™ Aspergillus EIA. In both patients the Aspergillus GM was barely above 0.5 index units, the FDA-cleared cut-off for positivity for serum and BAL. The physicians caring for these patients included aspergillosis or an endemic mycosis in the differential diagnosis, based upon underlying immunosuppression and consistent radiographic abnormalities.
Given the cross reactivity of the antigen detected in blastomycosis and histoplasmosis [3] and demonstration that Blastomyces culture supernatant caused positive results in the Platelia ™ Aspergillus EIA [2], cases of blastomycosis also could be expected to cause cross reaction in this assay. The mechanism for this cross-reactivity has not been fully studied. A GM is present in the urine, blood and BAL of patients with blastomycosis that is immunologically indistinguishable from that in histoplasmosis [3 -6] . H. capsulatum , B. dermatitidis and Paracoccidioides brasiliensis contain immunologically and chemically similar GMs in their cell walls, in which galactofuranose is present at the non-reducing terminals [7] . Galactofuranose is the epitope detected by the monoclonal antibodies [8] used in the Platelia Aspergillus EIA. The GM found in A. fumigatus contains (1 ® 5)-β galactofuranosyl side chains while Histoplasma GM has (1 ® 6)-α -D-galactofuranosyl side chains. Chemical differences in the galactofuranosyl side chains probably account for the weak cross reactivity seen with Aspergillus spp. and H. capsulatum [1] and B. dermatitidis and the strong cross reactivity between H. capsulatum , B. dermatitidis and P. brasiliensis [4] . Our preliminary fi ndings need to be confi rmed in larger studies.
Misdiagnosis of aspergillosis in a patient with blastomycosis may cause errors in the selection of antifungal therapy. For example, the echinocandins are not active or recommended for the treatment of blastomycosis and the role of voriconazole is unclear [9] . Care must be taken to exclude blastomycosis in patients with a positive 4 Thirdgeneration Blastomyces antigen assay, upper limit of quantifi cation is 14.7 ng/ml. 5 Third-generation Histoplasma antigen assay, results more than three times the negative control are positive, and those between the cut-off and the 0.6 ng/ml standard are reported as positive, less than 0.6 ng/ml and those above the upper limit of quantifi cation are reported as above 39 ng/ml.
Fig. 1
Broad budding yeast measuring between 6 and 10 micrometers in diameter (A) Giemsa stain, and (B) GMS. Images were taken originally at 1000 ϫ magnifi cation,
